$4.77
-0.07-1.45%
Last update: Nov 10, 6:26 AM
ENDRA Life Sciences Inc
NDRANASDAQ
The average analyst price target for ENDRA Life Sciences is $25, 426.3% above the current price. The one analyst covering it rates it Buy. The latest change came on Jun 1, 2026, when Ascendiant Capital lowered its price target on ENDRA Life Sciences from $27 to $25 and kept a Buy rating.
Price Target Range — 5 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
